Actively Recruiting
Phase 3 Trial Comparing Trilaciclib Versus Placebo for Limited-Stage Small Cell Lung Cancer to Prevent Bone Marrow Damage
Led by Pharmacosmos A/S · Updated on 2026-10-02
120
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating trilaciclib compared to a placebo in adults with limited-stage small cell lung cancer to determine if trilaciclib can protect the bone marrow from damage caused by chemotherapy. This Phase 3 clinical trial aims to assess the safety and effectiveness of trilaciclib in preventing myelosuppression, a condition where bone marrow activity is decreased, leading to fewer blood cells. Participants have a confirmed diagnosis of limited-stage small cell lung cancer and have recovered from prior tumor surgeries. Participants are randomly assigned to receive either trilaciclib or a placebo through intravenous infusion. This double-blind study means neither participants nor researchers know who receives the drug or placebo. The treatment period and follow-up extend from enrollment through 4 months after treatment to monitor effects. The key focus is on the prevention of myelosuppression and related complications such as chemotherapy dose reductions, infections, hospitalizations, and blood transfusions. During the study, participants will undergo tumor assessments and evaluations of blood cell counts to monitor bone marrow function and cancer status. Researchers will collect data on hospitalizations, infections like febrile neutropenia, and use of supportive treatments such as growth factors and blood transfusions. Safety and efficacy will be tracked throughout the treatment and follow-up periods. Participation involves regular visits for assessments and infusions, lasting approximately 4 months from enrollment.
CONDITIONS
Brief Title
Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Research Team
P
Pharmacosmos A/S Clinical and non-clinical research
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here